Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00256386 · ClinicalTrials.gov registry record · NA
LabAlert: Enhancing Medication Safety Through Electronic Interventions to Improve Laboratory Monitoring
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 800
- Enrollment target
NCT00256386 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 800 participants.
The verdict
NCT00256386, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
Study Summary
Errors and preventable adverse events associated with medication prescription and dispensing are common, and the difference between guideline recommendations and the actual frequency of laboratory monitoring is substantial. This study evaluates three interventions to improve laboratory monitoring at initiation of medication therapy: an electronic medical record reminder to the prescribing clinician (EMR), an automated voice message to the patient (AVM), and a pharmacy team outreach (Pharmacy) compared to usual care (UC).
Interventions
- DEVICE Electronic Medical Record (EMR) to clinician's in-basket
- DEVICE Automated Voice Message (AVM) reminder to patient's phone
- PROCEDURE Pharmacy Team phone call-letter followup
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2004-01 |
| Est. Completion | 2005-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00256386
The ClinicalTrials.gov registry entry for NCT00256386 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Electronic Medical Record (EMR) to clinician's in-basket is the first listed.
NCT00256386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00256386 about?
NCT00256386 is a clinical study titled "LabAlert: Enhancing Medication Safety Through Electronic Interventions to Improve Laboratory Monitoring". Errors and preventable adverse events associated with medication prescription and dispensing are common, and the difference between guideline recommendations and the actual frequency of laboratory monitoring is substantial. This study evaluates three interventions to improve laboratory monitoring at...
What is the current status of trial NCT00256386?
This trial is currently completed. It is a NA study. The enrollment target is 800 participants. The study started on 2004-01. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00256386?
The interventions under investigation include: Electronic Medical Record (EMR) to clinician's in-basket (DEVICE), Automated Voice Message (AVM) reminder to patient's phone (DEVICE), Pharmacy Team phone call-letter followup (PROCEDURE).
Who is sponsoring clinical trial NCT00256386?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.